A seven-figure buy from the CEO adds fuel while the stock builds a major base for what's to come ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Tuesday, December 2, 2025
|
|
|
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves. 📌 Alumis $ALMS — CEO Srinivas Akkaraju bought $1.31 Million, revealed by a new Form 4.
A meaningful biotech purchase from a top operator. Size stands out in the space and adds conviction as the stock continues to carve out a deep IPO base. 📌 Johnson & Johnson $JNJ — Director John Morikis bought $258,000 per a new Form 4.
A rare insider buy at a mega-cap healthcare bellwether. Small relative to its size, but seeing a director step in at all-time highs is telling. Here's The Hot Corner, with data from December 1, 2025: |
Click the table to enlarge it. |
📌 Baldwin Insurance Group $BWIN — William Blair IM boosted its 13G stake from 4.31% to 10.9%.
An aggressive increase — nearly tripling ownership. A strong institutional vote of confidence in a name that's halved since its highs over a year ago. 📌 Ashland $ASH — Standard Investments filed a new 13D at 5.7%.
A timely purchase as the stock jets higher off a key level of support, failing to complete a near decade-long distribution pattern. If you want this actionable trade ideas based on insider trading, join Hot Corner Insider risk-free. |
|
|
Alfonso De Pablos | Director of Research, All Star Charts |
|
|
Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media. |
Want to change how you receive these emails? You can manage your preferences here unsubscribe. © 2025 Stock Market Media 624 Broadway, Suite 405 San Diego, CA 92101 |
|
|
|